Subsequently, Mendelian randomization analysis revealed that HMGCR inhibition and PCSK9 inhibition were associated with a reduced risk of PCa, suggesting that HMGCR inhibition may exert its protective effect against PCa through lipid-lowering mechanisms. The gene discussed is PCSK9; the disease is posterior cortical atrophy.